Market Cap 648.55B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 25.34
Forward PE 23.71
Profit Margin 28.46%
Debt to Equity Ratio 0.44
Volume 6,125,000
Avg Vol 7,209,644
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 19%
Beta 0.24
Analysts Strong Sell
Price Target $278.04

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
MarcoFla99
MarcoFla99 Sep. 10 at 2:30 AM
$JNJ Sold 10% of my holdings today.
0 · Reply
dustlesspuma
dustlesspuma Sep. 9 at 9:10 PM
🔴 $JNJ 265P Sep 11 💰 $589,400 premium 💵 $0.9/contract 📊 9.9x Vol/OI 📍 Spot $269.04 💰 Large premium 🌊 Dark Flow | Options Flow
0 · Reply
Outcomes
Outcomes Sep. 9 at 8:58 PM
$IBRX $MRNA $MRK $PFE $JNJ Cardiac, oncologic, neurologic, immunologic.. mRNA BAD. SAVE THE CHILDREN. 🙏🏻 PSS KNOWS. https://x.com/fynnderella1/status/2097697348486860895?s=46
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 9 at 6:47 PM
$SLS $JNJ $MRK Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September 1, 2026. Mr. Cavanaugh officially took over last week. $JNJ Executives openly praising GPS Regal Pivotal Registrational Phase 3. 👇 ✌️🙏❤️‍🩹
0 · Reply
Gebinator
Gebinator Sep. 9 at 6:43 PM
$SLS while we marvel over the funny trading patterns of late, for entertainment and survey sampling value, let's explore those BPs chasing $JNJ and $MRK for some form of m&a transaction with $SLS. Who's the viable, reliable third (spoiler) for the 🏆
0 · Reply
Johnmtnb2018
Johnmtnb2018 Sep. 9 at 5:19 PM
$SLS $JNJ Keep an eye on JNJ. Katherine Kalin Bach is up to something very big !
0 · Reply
juice_rock
juice_rock Sep. 9 at 4:56 PM
$JNJ Based on the conference call today I'm predicting $JNJ buys out $SLS for the oncology portfolio upon release of successful REGAL trial data. Specifically: >JNJ wants solutions to "Unmet needs" in the context of oncology >JNJ wants to bring scalability that isn't there if the acquisition partner continues independently.
7 · Reply
juice_rock
juice_rock Sep. 9 at 3:43 PM
$SLS Just now on the $JNJ call with wells fargo healthcare conference, $JNJ regarding oncology acquisitions: >has the cashpile to make deals happen >Looking for solutions to unmet needs >JNJ wants to bring scalability that isn't there if the acquisition target continues independent I wonder who that could be??? 🤔🤔🤔🤔
2 · Reply
Outcomes
Outcomes Sep. 9 at 3:27 PM
$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. https://x.com/fa21519230/status/2097375843894911449?s=46
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 9 at 2:31 PM
$SLS $JNJ $MRK $PFE $BMY . Stergiou doesn’t need to announce anything if big pharmaceutical on the table makes a move and buys them out to avoid a bidding war post data. ✌️🙏❤️‍🩹
0 · Reply
Latest News on JNJ
Johnson & Johnson assumed with a Buy at UBS

2026-09-02T11:35:52.000Z - 7 days ago

Johnson & Johnson assumed with a Buy at UBS


China approves J&J's oral psoriasis pill, says drugmaker

Aug 27, 2026, 5:42 AM EDT - 13 days ago

China approves J&J's oral psoriasis pill, says drugmaker


US FDA expands approval for J&J's drug for rare blood disorder

Aug 24, 2026, 6:33 PM EDT - 16 days ago

US FDA expands approval for J&J's drug for rare blood disorder


Johnson & Johnson Transcript: Investor update

Aug 3, 2026, 8:00 AM EDT - 5 weeks ago

Johnson & Johnson Transcript: Investor update


Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Aug 2, 2026, 8:00 AM EDT - 5 weeks ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device


Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:38 PM EDT - 6 weeks ago

Johnson & Johnson lowers 2026 profit forecast


Explainer: Can J&J finally put the talc litigation behind it?

Jul 29, 2026, 12:01 PM EDT - 6 weeks ago

Explainer: Can J&J finally put the talc litigation behind it?


Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 12:26 PM EDT - 6 weeks ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits


J&J offers $5.5bn to settle baby powder lawsuits

Jul 28, 2026, 12:31 AM EDT - 6 weeks ago

J&J offers $5.5bn to settle baby powder lawsuits


DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 7 weeks ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Quarterly report: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 1 month ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 1 month ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 15, 2026, 6:20 AM EDT - 1 month ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 2 months ago

The Big 3: UNH, KO, JNJ

KO UNH


MarcoFla99
MarcoFla99 Sep. 10 at 2:30 AM
$JNJ Sold 10% of my holdings today.
0 · Reply
dustlesspuma
dustlesspuma Sep. 9 at 9:10 PM
🔴 $JNJ 265P Sep 11 💰 $589,400 premium 💵 $0.9/contract 📊 9.9x Vol/OI 📍 Spot $269.04 💰 Large premium 🌊 Dark Flow | Options Flow
0 · Reply
Outcomes
Outcomes Sep. 9 at 8:58 PM
$IBRX $MRNA $MRK $PFE $JNJ Cardiac, oncologic, neurologic, immunologic.. mRNA BAD. SAVE THE CHILDREN. 🙏🏻 PSS KNOWS. https://x.com/fynnderella1/status/2097697348486860895?s=46
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 9 at 6:47 PM
$SLS $JNJ $MRK Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September 1, 2026. Mr. Cavanaugh officially took over last week. $JNJ Executives openly praising GPS Regal Pivotal Registrational Phase 3. 👇 ✌️🙏❤️‍🩹
0 · Reply
Gebinator
Gebinator Sep. 9 at 6:43 PM
$SLS while we marvel over the funny trading patterns of late, for entertainment and survey sampling value, let's explore those BPs chasing $JNJ and $MRK for some form of m&a transaction with $SLS. Who's the viable, reliable third (spoiler) for the 🏆
0 · Reply
Johnmtnb2018
Johnmtnb2018 Sep. 9 at 5:19 PM
$SLS $JNJ Keep an eye on JNJ. Katherine Kalin Bach is up to something very big !
0 · Reply
juice_rock
juice_rock Sep. 9 at 4:56 PM
$JNJ Based on the conference call today I'm predicting $JNJ buys out $SLS for the oncology portfolio upon release of successful REGAL trial data. Specifically: >JNJ wants solutions to "Unmet needs" in the context of oncology >JNJ wants to bring scalability that isn't there if the acquisition partner continues independently.
7 · Reply
juice_rock
juice_rock Sep. 9 at 3:43 PM
$SLS Just now on the $JNJ call with wells fargo healthcare conference, $JNJ regarding oncology acquisitions: >has the cashpile to make deals happen >Looking for solutions to unmet needs >JNJ wants to bring scalability that isn't there if the acquisition target continues independent I wonder who that could be??? 🤔🤔🤔🤔
2 · Reply
Outcomes
Outcomes Sep. 9 at 3:27 PM
$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. https://x.com/fa21519230/status/2097375843894911449?s=46
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 9 at 2:31 PM
$SLS $JNJ $MRK $PFE $BMY . Stergiou doesn’t need to announce anything if big pharmaceutical on the table makes a move and buys them out to avoid a bidding war post data. ✌️🙏❤️‍🩹
0 · Reply
Estimize
Estimize Sep. 9 at 2:09 PM
Wall St is expecting 2.90 EPS for $JNJ Q3 [Reporting 10/13 BMO] http://www.estimize.com/intro/jnj?chart=historical&metric_name=eps&utm_cont
0 · Reply
Outcomes
Outcomes Sep. 9 at 11:30 AM
$IBRX $MRNA $MRK $PFE $JNJ All planned. PSS KNOWS. 'Follow The Money'. William Gates Sr. was a known eugenicist Bill Gates money all over big pharmaceutical and regulatory bodies.
0 · Reply
Outcomes
Outcomes Sep. 9 at 11:25 AM
$IBRX $JNJ $MRK $MRNA $PFE mRNA BAD. ‘Act Of War’ ‘Emergency Use Authorization’ Hugh Auchincloss, NIH, office next to Fauci Hugh Auchincloss Sr. was oncologist in Ridgewood, NJ using experimental chemotherapy drugs. He treated my 2 sisters. Jake Auchincloss, son of Hugh Jr., congressman in Massachusetts. https://x.com/loop_rm_3117211/status/2097300713814540651?s=46
0 · Reply
Outcomes
Outcomes Sep. 9 at 10:55 AM
$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. PSS KNOWS. SAVE THE CHILDREN. 🙏 https://x.com/DaveFreedom4/status/2097068995505709494?s=20
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Sep. 9 at 4:46 AM
$JNJ $AMGN $AZN $GILD $PFE SEP 11 PDUFA for Midcap Oncology Biotech TLX (Friday), below.
0 · Reply
focafoca99
focafoca99 Sep. 8 at 1:08 PM
$JNJ spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026. https://www.rapidticker.com/news/jnj-johnson-johnson-spotlights-new-neuropsychiatry-f42d25
0 · Reply
harmongreg
harmongreg Sep. 8 at 12:52 PM
4 Trade Ideas for Johnson & Johnson: Bonus Idea $JNJ https://dragonflycap.com/4-trade-ideas-for-johnson-johnson-bonus-idea-13/
1 · Reply
Outcomes
Outcomes Sep. 8 at 11:31 AM
$IBRX $MRNA.X $MRK $PFE $JNJ ….why rebrand problems!? 🤔 MRNA BAD. PSS KNOWS. https://products.modernatx.com/mnexspikepro?utm_medium=paidsearch&utm_source=bing&utm_campaign=hcp1283&utm_term=65&utm_content=brandedkeywords&&msclkid=c3547d76fa4719a56b6517e9b926266b&utm_source=bing&utm_medium=cpc&utm_campaign=MODERNA_HCP%201283%20MNEXSPIKE_US_BING%20SEARCH_CONVERSION_P3JKPKP_2026_July-Oct_Traffic_CPC_Branded_%5BKNOWN%5D&utm_term=mNEXSPIKE&utm_content=HCP%20Evergreen%20-%20General&gclid=c3547d76fa4719a56b6517e9b926266b&gclsrc=3p.ds
0 · Reply
PhantomZ
PhantomZ Sep. 6 at 9:47 PM
$TLTFF taken from AI…. A competition killer? $IBRX $CGON $MRK $JNJ https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=37107118
0 · Reply
grampslol
grampslol Sep. 5 at 7:21 PM
$MNKD 31 Vice Presidents... 1 flop drug , afrezza dpi inhaled prandial insulin approved in 2014 ... the only insulin with the FDA black box warning label dumped by $SNY over a decade ago ... $JNJ $LLY $LQDA
2 · Reply
SignalYieldAI
SignalYieldAI Sep. 5 at 5:06 PM
Conservative Investing / Real Yield Nominal yield and real yield tell very different stories right now. Gold Futures top the list at 20.61% real yield (23.91% nominal) — despite the metal itself being down 0.32% today, the inflation-adjusted return still leads everything on the board. Meanwhile two "safe" dividend names actually show negative real yield: $PLD (Prologis) at -0.32% and $JNJ (Johnson & Johnson) at -0.98%. Both pay a nominal dividend (2.98% and 2.32%), but with CPI running at 3.30%, that income gets fully eaten by inflation and then some. US Treasury yield curve is holding a normal upward slope (4.1% at 1Y to 5.25% at 30Y), credit spreads still reading Normal. Nominal yield isn't the number that pays your bills in real terms — the gap between the two can flip which asset actually protects you. NFA. Information for consideration only. via Signal Yield AI — Conservative Investing
0 · Reply
EnricoPalazo
EnricoPalazo Sep. 5 at 11:54 AM
$XBI saw an analysis that the new 340B rule has a 70% chance of going into effect in Jan. Who knows? but if it does, hospitals purge Medicare and MA medically billed drug patients and they go to other sites of care paying full price on drugs. Is $XBI the bet or a basket with $JNJ, $BMY and $MRK ?
0 · Reply